Global Gastrointestinal Cancer Drug Sales Market Report 2017

Table of Contents

Global Gastrointestinal Cancer Drug Sales Market Report 2017
1 Gastrointestinal Cancer Drug Market Overview
1.1 Product Overview and Scope of Gastrointestinal Cancer Drug
1.2 Classification of Gastrointestinal Cancer Drug by Product Category
1.2.1 Global Gastrointestinal Cancer Drug Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Gastrointestinal Cancer Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Immunotherapy
1.2.4 Chemotherapy
1.2.5 Targeted Therapy
1.2.6 Radiation Therapy
1.2.7 Hormone Therapy
1.2.8 Adjuvant Chemotherapy
1.3 Global Gastrointestinal Cancer Drug Market by Application/End Users
1.3.1 Global Gastrointestinal Cancer Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Radiology
1.3.3 Oncology
1.4 Global Gastrointestinal Cancer Drug Market by Region
1.4.1 Global Gastrointestinal Cancer Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.3 China Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.4 Europe Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.5 Japan Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.6 Southeast Asia Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.4.7 India Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Gastrointestinal Cancer Drug (2012-2022)
1.5.1 Global Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2022)
1.5.2 Global Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2022)

2 Global Gastrointestinal Cancer Drug Competition by Players/Suppliers, Type and Application
2.1 Global Gastrointestinal Cancer Drug Market Competition by Players/Suppliers
2.1.1 Global Gastrointestinal Cancer Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Gastrointestinal Cancer Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Gastrointestinal Cancer Drug (Volume and Value) by Type
2.2.1 Global Gastrointestinal Cancer Drug Sales and Market Share by Type (2012-2017)
2.2.2 Global Gastrointestinal Cancer Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Gastrointestinal Cancer Drug (Volume and Value) by Region
2.3.1 Global Gastrointestinal Cancer Drug Sales and Market Share by Region (2012-2017)
2.3.2 Global Gastrointestinal Cancer Drug Revenue and Market Share by Region (2012-2017)
2.4 Global Gastrointestinal Cancer Drug (Volume) by Application

3 United States Gastrointestinal Cancer Drug (Volume, Value and Sales Price)
3.1 United States Gastrointestinal Cancer Drug Sales and Value (2012-2017)
3.1.1 United States Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)
3.1.2 United States Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)
3.1.3 United States Gastrointestinal Cancer Drug Sales Price Trend (2012-2017)
3.2 United States Gastrointestinal Cancer Drug Sales Volume and Market Share by Players
3.3 United States Gastrointestinal Cancer Drug Sales Volume and Market Share by Type
3.4 United States Gastrointestinal Cancer Drug Sales Volume and Market Share by Application

4 China Gastrointestinal Cancer Drug (Volume, Value and Sales Price)
4.1 China Gastrointestinal Cancer Drug Sales and Value (2012-2017)
4.1.1 China Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)
4.1.2 China Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)
4.1.3 China Gastrointestinal Cancer Drug Sales Price Trend (2012-2017)
4.2 China Gastrointestinal Cancer Drug Sales Volume and Market Share by Players
4.3 China Gastrointestinal Cancer Drug Sales Volume and Market Share by Type
4.4 China Gastrointestinal Cancer Drug Sales Volume and Market Share by Application

5 Europe Gastrointestinal Cancer Drug (Volume, Value and Sales Price)
5.1 Europe Gastrointestinal Cancer Drug Sales and Value (2012-2017)
5.1.1 Europe Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)
5.1.2 Europe Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)
5.1.3 Europe Gastrointestinal Cancer Drug Sales Price Trend (2012-2017)
5.2 Europe Gastrointestinal Cancer Drug Sales Volume and Market Share by Players
5.3 Europe Gastrointestinal Cancer Drug Sales Volume and Market Share by Type
5.4 Europe Gastrointestinal Cancer Drug Sales Volume and Market Share by Application

6 Japan Gastrointestinal Cancer Drug (Volume, Value and Sales Price)
6.1 Japan Gastrointestinal Cancer Drug Sales and Value (2012-2017)
6.1.1 Japan Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)
6.1.2 Japan Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)
6.1.3 Japan Gastrointestinal Cancer Drug Sales Price Trend (2012-2017)
6.2 Japan Gastrointestinal Cancer Drug Sales Volume and Market Share by Players
6.3 Japan Gastrointestinal Cancer Drug Sales Volume and Market Share by Type
6.4 Japan Gastrointestinal Cancer Drug Sales Volume and Market Share by Application

7 Southeast Asia Gastrointestinal Cancer Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Gastrointestinal Cancer Drug Sales and Value (2012-2017)
7.1.1 Southeast Asia Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Gastrointestinal Cancer Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Gastrointestinal Cancer Drug Sales Volume and Market Share by Players
7.3 Southeast Asia Gastrointestinal Cancer Drug Sales Volume and Market Share by Type
7.4 Southeast Asia Gastrointestinal Cancer Drug Sales Volume and Market Share by Application

8 India Gastrointestinal Cancer Drug (Volume, Value and Sales Price)
8.1 India Gastrointestinal Cancer Drug Sales and Value (2012-2017)
8.1.1 India Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)
8.1.2 India Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)
8.1.3 India Gastrointestinal Cancer Drug Sales Price Trend (2012-2017)
8.2 India Gastrointestinal Cancer Drug Sales Volume and Market Share by Players
8.3 India Gastrointestinal Cancer Drug Sales Volume and Market Share by Type
8.4 India Gastrointestinal Cancer Drug Sales Volume and Market Share by Application

9 Global Gastrointestinal Cancer Drug Players/Suppliers Profiles and Sales Data
9.1 Celgene Corporation
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Celgene Corporation Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Eli Lilly and Company
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Eli Lilly and Company Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline plc.
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Pfizer Inc.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Pfizer Inc. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Sanofi
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Sanofi Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Novartis AG.
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Novartis AG. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Bristol-Myers Squibb Company
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Amgen Limited & Amgen Ireland Limited
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Johnson & Johnson Private Limited
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview

10 Gastrointestinal Cancer Drug Maufacturing Cost Analysis
10.1 Gastrointestinal Cancer Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Gastrointestinal Cancer Drug
10.3 Manufacturing Process Analysis of Gastrointestinal Cancer Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Gastrointestinal Cancer Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Gastrointestinal Cancer Drug Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Gastrointestinal Cancer Drug Market Forecast (2017-2022)
14.1 Global Gastrointestinal Cancer Drug Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Gastrointestinal Cancer Drug Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Gastrointestinal Cancer Drug Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Gastrointestinal Cancer Drug Price and Trend Forecast (2017-2022)
14.2 Global Gastrointestinal Cancer Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Gastrointestinal Cancer Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Gastrointestinal Cancer Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Gastrointestinal Cancer Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Gastrointestinal Cancer Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Gastrointestinal Cancer Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Gastrointestinal Cancer Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Gastrointestinal Cancer Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Gastrointestinal Cancer Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Gastrointestinal Cancer Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Gastrointestinal Cancer Drug Sales Forecast by Type (2017-2022)
14.3.2 Global Gastrointestinal Cancer Drug Revenue Forecast by Type (2017-2022)
14.3.3 Global Gastrointestinal Cancer Drug Price Forecast by Type (2017-2022)
14.4 Global Gastrointestinal Cancer Drug Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Gastrointestinal Cancer Drug
Figure Global Gastrointestinal Cancer Drug Sales Volume Comparison (MT) by Type (2012-2022)
Figure Global Gastrointestinal Cancer Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Immunotherapy Product Picture
Figure Chemotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Radiation Therapy Product Picture
Figure Hormone Therapy Product Picture
Figure Adjuvant Chemotherapy Product Picture
Figure Global Gastrointestinal Cancer Drug Sales Comparison (MT) by Application (2012-2022)
Figure Global Sales Market Share of Gastrointestinal Cancer Drug by Application in 2016
Figure Radiology Examples
Table Key Downstream Customer in Radiology
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Global Gastrointestinal Cancer Drug Market Size (Million USD) by Regions (2012-2022)
Figure United States Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Gastrointestinal Cancer Drug Sales Volume (MT) and Growth Rate (2012-2022)
Figure Global Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Gastrointestinal Cancer Drug Sales Volume (MT) (2012-2017)
Table Global Gastrointestinal Cancer Drug Sales (MT) of Key Players/Suppliers (2012-2017)
Table Global Gastrointestinal Cancer Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Gastrointestinal Cancer Drug Sales Share by Players/Suppliers
Figure 2017 Gastrointestinal Cancer Drug Sales Share by Players/Suppliers
Figure Global Gastrointestinal Cancer Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Gastrointestinal Cancer Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Gastrointestinal Cancer Drug Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Gastrointestinal Cancer Drug Revenue Share by Players
Table 2017 Global Gastrointestinal Cancer Drug Revenue Share by Players
Table Global Gastrointestinal Cancer Drug Sales (MT) and Market Share by Type (2012-2017)
Table Global Gastrointestinal Cancer Drug Sales Share (MT) by Type (2012-2017)
Figure Sales Market Share of Gastrointestinal Cancer Drug by Type (2012-2017)
Figure Global Gastrointestinal Cancer Drug Sales Growth Rate by Type (2012-2017)
Table Global Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Gastrointestinal Cancer Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drug by Type (2012-2017)
Figure Global Gastrointestinal Cancer Drug Revenue Growth Rate by Type (2012-2017)
Table Global Gastrointestinal Cancer Drug Sales Volume (MT) and Market Share by Region (2012-2017)
Table Global Gastrointestinal Cancer Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Gastrointestinal Cancer Drug by Region (2012-2017)
Figure Global Gastrointestinal Cancer Drug Sales Growth Rate by Region in 2016
Table Global Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Gastrointestinal Cancer Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drug by Region (2012-2017)
Figure Global Gastrointestinal Cancer Drug Revenue Growth Rate by Region in 2016
Table Global Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Gastrointestinal Cancer Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drug by Region (2012-2017)
Figure Global Gastrointestinal Cancer Drug Revenue Market Share by Region in 2016
Table Global Gastrointestinal Cancer Drug Sales Volume (MT) and Market Share by Application (2012-2017)
Table Global Gastrointestinal Cancer Drug Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Gastrointestinal Cancer Drug by Application (2012-2017)
Figure Global Gastrointestinal Cancer Drug Sales Market Share by Application (2012-2017)
Figure United States Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure United States Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Gastrointestinal Cancer Drug Sales Price (USD/Kg) Trend (2012-2017)
Table United States Gastrointestinal Cancer Drug Sales Volume (MT) by Players (2012-2017)
Table United States Gastrointestinal Cancer Drug Sales Volume Market Share by Players (2012-2017)
Figure United States Gastrointestinal Cancer Drug Sales Volume Market Share by Players in 2016
Table United States Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2017)
Table United States Gastrointestinal Cancer Drug Sales Volume Market Share by Type (2012-2017)
Figure United States Gastrointestinal Cancer Drug Sales Volume Market Share by Type in 2016
Table United States Gastrointestinal Cancer Drug Sales Volume (MT) by Application (2012-2017)
Table United States Gastrointestinal Cancer Drug Sales Volume Market Share by Application (2012-2017)
Figure United States Gastrointestinal Cancer Drug Sales Volume Market Share by Application in 2016
Figure China Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Price (USD/Kg) Trend (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Volume (MT) by Players (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Volume Market Share by Players (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Volume Market Share by Players in 2016
Table China Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Volume Market Share by Type (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Volume Market Share by Type in 2016
Table China Gastrointestinal Cancer Drug Sales Volume (MT) by Application (2012-2017)
Table China Gastrointestinal Cancer Drug Sales Volume Market Share by Application (2012-2017)
Figure China Gastrointestinal Cancer Drug Sales Volume Market Share by Application in 2016
Figure Europe Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Europe Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Gastrointestinal Cancer Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Europe Gastrointestinal Cancer Drug Sales Volume (MT) by Players (2012-2017)
Table Europe Gastrointestinal Cancer Drug Sales Volume Market Share by Players (2012-2017)
Figure Europe Gastrointestinal Cancer Drug Sales Volume Market Share by Players in 2016
Table Europe Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2017)
Table Europe Gastrointestinal Cancer Drug Sales Volume Market Share by Type (2012-2017)
Figure Europe Gastrointestinal Cancer Drug Sales Volume Market Share by Type in 2016
Table Europe Gastrointestinal Cancer Drug Sales Volume (MT) by Application (2012-2017)
Table Europe Gastrointestinal Cancer Drug Sales Volume Market Share by Application (2012-2017)
Figure Europe Gastrointestinal Cancer Drug Sales Volume Market Share by Application in 2016
Figure Japan Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Japan Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Gastrointestinal Cancer Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Japan Gastrointestinal Cancer Drug Sales Volume (MT) by Players (2012-2017)
Table Japan Gastrointestinal Cancer Drug Sales Volume Market Share by Players (2012-2017)
Figure Japan Gastrointestinal Cancer Drug Sales Volume Market Share by Players in 2016
Table Japan Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2017)
Table Japan Gastrointestinal Cancer Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Gastrointestinal Cancer Drug Sales Volume Market Share by Type in 2016
Table Japan Gastrointestinal Cancer Drug Sales Volume (MT) by Application (2012-2017)
Table Japan Gastrointestinal Cancer Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Gastrointestinal Cancer Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drug Sales Price (USD/Kg) Trend (2012-2017)
Table Southeast Asia Gastrointestinal Cancer Drug Sales Volume (MT) by Players (2012-2017)
Table Southeast Asia Gastrointestinal Cancer Drug Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drug Sales Volume Market Share by Players in 2016
Table Southeast Asia Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia Gastrointestinal Cancer Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Gastrointestinal Cancer Drug Sales Volume (MT) by Application (2012-2017)
Table Southeast Asia Gastrointestinal Cancer Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drug Sales Volume Market Share by Application in 2016
Figure India Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)
Figure India Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Gastrointestinal Cancer Drug Sales Price (USD/Kg) Trend (2012-2017)
Table India Gastrointestinal Cancer Drug Sales Volume (MT) by Players (2012-2017)
Table India Gastrointestinal Cancer Drug Sales Volume Market Share by Players (2012-2017)
Figure India Gastrointestinal Cancer Drug Sales Volume Market Share by Players in 2016
Table India Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2017)
Table India Gastrointestinal Cancer Drug Sales Volume Market Share by Type (2012-2017)
Figure India Gastrointestinal Cancer Drug Sales Volume Market Share by Type in 2016
Table India Gastrointestinal Cancer Drug Sales Volume (MT) by Application (2012-2017)
Table India Gastrointestinal Cancer Drug Sales Volume Market Share by Application (2012-2017)
Figure India Gastrointestinal Cancer Drug Sales Volume Market Share by Application in 2016
Table Celgene Corporation Basic Information List
Table Celgene Corporation Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Sales Global Market Share (2012-2017
Figure Celgene Corporation Gastrointestinal Cancer Drug Revenue Global Market Share (2012-2017)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales Global Market Share (2012-2017
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Revenue Global Market Share (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Sales Global Market Share (2012-2017
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline plc. Basic Information List
Table GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales Global Market Share (2012-2017
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Revenue Global Market Share (2012-2017)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Sales Global Market Share (2012-2017
Figure Pfizer Inc. Gastrointestinal Cancer Drug Revenue Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Sales Global Market Share (2012-2017
Figure Sanofi Gastrointestinal Cancer Drug Revenue Global Market Share (2012-2017)
Table Novartis AG. Basic Information List
Table Novartis AG. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Sales Global Market Share (2012-2017
Figure Novartis AG. Gastrointestinal Cancer Drug Revenue Global Market Share (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales Global Market Share (2012-2017
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Revenue Global Market Share (2012-2017)
Table Amgen Limited & Amgen Ireland Limited Basic Information List
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales Global Market Share (2012-2017
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Revenue Global Market Share (2012-2017)
Table Johnson & Johnson Private Limited Basic Information List
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales Global Market Share (2012-2017
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal Cancer Drug
Figure Manufacturing Process Analysis of Gastrointestinal Cancer Drug
Figure Gastrointestinal Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal Cancer Drug Major Players in 2016
Table Major Buyers of Gastrointestinal Cancer Drug
Table Distributors/Traders List
Figure Global Gastrointestinal Cancer Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Global Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Gastrointestinal Cancer Drug Price (USD/Kg) and Trend Forecast (2017-2022)
Table Global Gastrointestinal Cancer Drug Sales Volume (MT) Forecast by Regions (2017-2022)
Figure Global Gastrointestinal Cancer Drug Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Gastrointestinal Cancer Drug Sales Volume Market Share Forecast by Regions in 2022
Table Global Gastrointestinal Cancer Drug Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Gastrointestinal Cancer Drug Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Gastrointestinal Cancer Drug Revenue Market Share Forecast by Regions in 2022
Figure United States Gastrointestinal Cancer Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Gastrointestinal Cancer Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure China Gastrointestinal Cancer Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Gastrointestinal Cancer Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Europe Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Gastrointestinal Cancer Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Gastrointestinal Cancer Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Gastrointestinal Cancer Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure India Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Gastrointestinal Cancer Drug Sales (MT) Forecast by Type (2017-2022)
Figure Global Gastrointestinal Cancer Drug Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Gastrointestinal Cancer Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Gastrointestinal Cancer Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Gastrointestinal Cancer Drug Price (USD/Kg) Forecast by Type (2017-2022)
Table Global Gastrointestinal Cancer Drug Sales (MT) Forecast by Application (2017-2022)
Figure Global Gastrointestinal Cancer Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.